Escitalopram for first-time depression
Treatments studied
Part of Mental health clinical trials.
This trial tests whether escitalopram, a common antidepressant, helps people who are experiencing their first episode of depression and have never taken medication for it. It also looks at how the drug works in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old and of Han Chinese ethnicity.
- You have been diagnosed with major depression for the first time, for no more than 3 months.
- You have never taken antidepressants or other psychiatric medications.
- You score at least 17 on a standard depression scale (HAMD-17).
- You do not have other mental health conditions like bipolar disorder or psychosis.
- You are not pregnant, breastfeeding, or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a gentle brain stimulation treatment called tACS for teens aged 12-18 who are having their first episode of depression and have not taken any antidepressant medication. It aims to see if this non-invasive treatment can help improve depression symptoms safely.
This trial tests whether transplanting healthy gut bacteria (fecal microbiota) can help people with depression that does not respond well to the antidepressant escitalopram. You will first take escitalopram for 2 weeks, and if it doesn't help enough, you may receive either the real transplant or a placebo capsule.
This study measures how the antidepressant escitalopram builds up in the blood of women before and after menopause. It aims to see if hormone changes affect drug levels, which could help doctors adjust doses for better treatment.
This study tests whether adding acupuncture to escitalopram (an antidepressant) helps people with major depression feel better. It will also compare how the treatment is tolerated and whether depressive symptoms improve.
This Phase 4 study tests an “optimized” medication approach for adults with major depressive disorder (unipolar depression) based on how you respond over time. It may help your care team choose treatments more effectively and reduce trial-and-error.
This study tests which treatment sequence works best for people with anxiety conditions (generalized, social, separation) and/or panic, who also have significant depression/anxiety symptoms. It may help you find a more effective step-by-step plan and compare treatment orders.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.